Billionaire Profile
Li Ge
Global Rank
#496

Image: Office of Governor Deval Patrick of Massachusetts | Public domain | via Wikimedia Commons

Li Ge

CEO, Pharmaceuticals
UNITED STATES
Real-Time Net Worth
$7.626B
Estimated based on Pharmaceuticals stock value as of April 21, 2026
+0.16% (24h)
Age
59
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
UNITED STATES

Biography

Li Ge is a Chinese-American billionaire entrepreneur and philanthropist, best known as the founder, chairman, and CEO of WuXi AppTec, a global leader in pharmaceutical research, development, and manufacturing services. With an estimated net worth of $7.5 billion as of 2024, Li has built his wealth through his significant stakes in WuXi AppTec and its subsidiary WuXi Biologics. His career is marked by his expertise in the pharmaceutical industry, his commitment to innovation, and his contributions to philanthropy. He has been instrumental in shaping the pharmaceutical landscape.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/21/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Li Ge was born in Beijing, China, in January 1967. Details about his early life and family are limited, but he graduated from the Affiliated High School of Peking University. He earned a Bachelor of Arts degree in Chemistry from Peking University in July 1989. He then pursued his Ph.D. in organic chemistry at Columbia University in New York, graduating in 1994. His mentors at Columbia included W. Clark Still and Koji Nakanishi.

Rise to Success

Li Ge's professional journey began with a role at Pharmacopeia, Inc., where he served as a founding scientist. In 2000, inspired by a business trip to China, Li Ge co-founded WuXi AppTec in Shanghai with his wife, Ning Zhao. The company started as a contract research organization (CRO) providing services to global pharmaceutical and biotech companies. Under his leadership, WuXi AppTec expanded significantly, going public on the New York Stock Exchange in 2007, delisting in 2015, and relisting on the Shanghai and Hong Kong stock exchanges in 2018.

Key Business Strategies

Li Ge's strategic vision has been pivotal in WuXi AppTec's growth. The company specializes in drug discovery, testing, and clinical trial services. WuXi AppTec's success is also attributable to its commitment to providing cost-effective research solutions. Furthermore, the company has expanded its global presence with operations across Asia, Europe, and North America.

Philanthropy

Through the Ge Li & Ning Zhao Family Foundation, Li has prioritized advancing education, healthcare, and scientific research. The foundation has focused on STEM scholarships and endowments and has donated to several initiatives in healthcare and cancer research. Following the passing of his wife, the foundation has increased its focus on initiatives to honor her legacy.

Career Milestones

2000

Co-founded WuXi AppTec

Founded WuXi AppTec in Shanghai, China, with his wife, Ning Zhao. The company provides research and development services to the pharmaceutical and biotechnology industries.

2007

WuXi AppTec IPO on NYSE

WuXi AppTec went public on the New York Stock Exchange, raising capital for expansion.

2018

WuXi AppTec Relisting

Relisted on the Shanghai and Hong Kong stock exchanges, expanding operations globally.

Philanthropy & Social Impact

Healthcare

Ge Li & Ning Zhao Family Foundation

$20M

Donated to Memorial Sloan Kettering Cancer Center in 2020 to support lung cancer research.

Healthcare

Ge Li & Ning Zhao Family Foundation

$10M

Donated to Dana-Farber Cancer Institute in 2024 to establish the Ning Zhao Center for Oncology Nursing Education and Practice.

Education

Lige-Zhaoning Education Fund

100M RMB

Established at Peking University to support excellent scholars and scientists.

Business Philosophy & Leadership

Leadership Principles

Innovation

Driving innovation in the pharmaceutical research and development field.

Cost-Effectiveness

Providing cost-effective R&D services.

Controversies & Challenges

2024

BIOSECURE Act Concerns

Li co-signed an open letter rejecting allegations against WuXi AppTec regarding national security concerns.